Vakalyuk, I.I. and Virstyuk, N.G. 2018. Diagnostic significance of the newest biomarkers of steatosis progression in patients with stable coronary heart disease, combined with nonalcoholic fatty liver disease. Current issues in pharmacy and medicine: science and practice. 1 (Feb. 2018). DOI:https://doi.org/10.14739/2409-2932.2018.1.123648.